GLP-1s Show No Link to AKI With Anticancer Therapy

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

While some cancer treatments have a known AKI risk, exposure to GLP-1 receptor agonist drugs shows no added risk.
Medscape Medical News